These medtech companies raised the most VC last year
[Image from unsplash.com]Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry.
VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving medical device companies last year.
The companies raking in the VC cash are doing everything from creating robotic microsurgery for the eyes to building better dialysis machines to bringing neuromodulation to bear on epilepsy.
Read on to discover which medtech com...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Funding Roundup Hospital Care Implants mHealth (Mobile Health) Advanced Cardiac Therapeutics Inc. Auris Surgical Robotics Cereve EarLens Ebb Therapeutics EBR Systems Inc. Fractyl Laboratories immusant MedTech Mox Source Type: news
Thai woman left with silicone implant between her eyes
The unnamed woman, from Hat Yai in the south of the country, opted for a cheap rhinoplasty operation at a clinic that later refused to help her, local reports state. (Source: the Mail online | Health)
Source: the Mail online | Health - December 27, 2017 Category: Consumer Health News Source Type: news
Second Sight launches Argus retinal prosthesis in Iran
Second Sight Medical (NSDQ:EYES) said today it launched its Argus II retinal prosthesis system in Iran, facilitated through its exclusive distribution partner Arshia Gostar Darman.
The Sylmar, Calif.-based company said that the system has been implanted in two patients in the country, with the procedures performed by Dr. Mohsen Farvadin at the Shiraz Pars Hospital and Khalili Hospital, Shiraz Medical Science University in 44-year old and 33-year old patients with retinitis pigmentosa.
The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with e...
Source: Mass Device - December 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Optical/Ophthalmic Second Sight Source Type: news
Could an Implant Be Developed to Help Restore Sight?
Scientists from a biomedical research consortium could help a U.S. government funded program aiming to restore sensory perception. The U.S. Defense Advanced Research Projects Agency (DARPA) established the Neural Engineering System Design program (NESD) to encourage development of “an implantable neural interface able to provide unprecedented signal resolution and data-transfer bandwidth between the human brain and the digital world,” according to DARPA’s Web site.
DARPA has awarded six NESD contracts, one of which was given to CorticalSight, a program by the Seeing and Hearing Foundation (Fondation Voir et Entendre;...
Source: MDDI - November 30, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Implants Source Type: news
Report: India eyes penalties for Johnson & Johnson over metal-on-metal hips
Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the company elsewhere.
The world’s second-largest medical device maker has fielded numerous lawsuits about its ASR metal-on-metal hip replacement since it pulled the ASR XL Acetabular and ASR Hip Resurfacing systems from the market in August 2010, “due to the number of patients who required a second hip replacement procedure, called a revision surgery.” Three years later Johnson & Johnson pulled th...
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Legal News Metal-on-Metal johnsonandjohnson Source Type: news
Baby born with no eyes needs bionic implants
Archie Innes was born with a rare genetic disorder that has left him 'black blind'. Mother Fiona Gould, living in Sydney and originally from Kent, has raised £6,000 in just two days for the innovative treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2017 Category: Consumer Health News Source Type: news
FDA puts Second Sight Medical ’ s next-gen Orion ‘ bionic eye ’ on the fast track
Second Sight Medical (NSDQ:EYES) said today that the FDA put its Orion “bionic eye” on the fast track to approval.
The Orion device is a cortical visual prosthesis that uses a camera and a brain implant to bypass the optic nerve in visually impaired patients. The federal safety watchdog put the device on its expedited access pathway, giving Sylmar, Calif.-based Second Sight priority review, greater interactive review for both its investigational device exemption and pre-market approval bids, plus more emphasis on post-market studies rather than pre-market clinical work. The FDA will also assign a cross-discipli...
Source: Mass Device - November 8, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance Second Sight Source Type: news
The eyes have it: how technology allows you to speak when all you can do is blink
Developments in eye-gaze technology – which converts minute movements of the eye into spoken words – are opening up undreamed of opportunities for people with motor neurone syndromeSteve Thomas and I are talking about brain implants. Bonnie Tyler ’s Holding Out For a Hero is playing in the background and for a moment I almost forget that a disease has robbed Steve of his speech. The conversation breaks briefly; now I see his wheelchair, his ventilator, his hospital bed.Steve, a software engineer, was diagnosed with ALS (amyotrophic lateral sclerosis, a type ofmotor neurone disease) aged 50. He knew it was progre...
Source: Guardian Unlimited Science - October 16, 2017 Category: Science Authors: Jules Montague Tags: Motor neurone disease Medical research Technology Society Science Health & wellbeing Life and style Source Type: news
7 medtech stories we missed this week: Oct. 6, 2017
[Image from unsplash.com]From Intellijoint’s CE Mark to Patrona Medical and Kopis’ new partnership, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Intellijoint CE Mark for flagship hip navigation
Intellijoint surgical announced in an Oct. 4 press release that it has received CE Mark for its Intellijoint HIP System in Europe. The device is a 3D mini-optical navigation system that gives surgeons precise measurement for cup position, leg length and offset of total hip arthroplasty. It doesn’t require any pre-operative or intra-operative imaging and can be used with...
Source: Mass Device - October 6, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Biotech Blood Management Catheters Clinical Trials Food & Drug Administration (FDA) Hospital Care Optical/Ophthalmic Patient Monitoring Regulatory/Compliance Research & Development Adhezion Biomedical Bio-Tissue Inc. DiscG Source Type: news
Nerve implant 'restores consciousness' to man in vegetative state
Stimulation of the vagus nerve allows patient who has been in a vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a vegetative state for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in a vegetative state for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news
Nerve implant 'restores consciousness' to man in persistent vegetative state
Stimulation of the vagus nerve allows patient who had been in a persistent vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a persistent vegetative state (PVS) for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in PVS for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news
Nerve implant 'restores consciousness' to man in persistant vegetative state
Stimulation of the vagus nerve allows patient who had been in a persistant vegetative state for 15 years to track objects with his eyes and respond to simple requestsA 35-year-old man who had been in a persistant vegetative state (PVS) for 15 years has shown signs of consciousness after receiving a pioneering therapy involving nerve stimulation.The treatment challenges a widely-accepted view that there is no prospect of a patient recovering consciousness if they have been in PVS for longer than 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2017 Category: Science Authors: Hannah Devlin Science correspondent Tags: Neuroscience Medical research Source Type: news
FDA clears Second Sight IDE trial of next-gen Orion cortical visual prosthesis
Second Sight Medical (NSDQ:EYES) said today it won FDA investigational device exemption to initiate a feasibility clinical study of its Orion cortical visual prosthesis system.
The conditional approval gives the Sylmar, Calif.-based company clearance to enroll up to 5 patients at 2 US sites, but requires that the company conduct additional device testing and “address outstanding questions” within 45 days, it said.
“This is an exciting milestone for the company given the potential of Orion to provide useful vision to millions of blind individuals worldwide who have no other option today. We are delighted ...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Optical/Ophthalmic Prosthetics second-sight-medical Source Type: news
Abbott launches trial of transcatheter tricuspid repair device, eyes CE Mark
Abbott (NYSE:ABT) said today it enrolled the 1st patient in a clinical trial of a minimally invasive, clip-based transcatheter valve repair system for treating patients with severe tricuspid regurgitation, looking to eventually support CE Mark approval in the European Union.
The 1st patient in the trial was enrolled at the Abbott Northwestern Hospital by Dr. Paul Sorajja of the Minneapolis Heart Institute, the Abbot Park, Ill.-based company said.
The transcatheter tricuspid valve repair system is built off of technology which has been tested with the company’s MitraClip system, designed to treat mitral valve regurg...
Source: Mass Device - August 9, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Replacement Heart Valves Abbott Source Type: news
Simulations signal early success for fractal-based retinal implants
(University of Oregon) Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2017 Category: International Medicine & Public Health Source Type: news
